Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Evidence- |
RCV000495779 | SCV000578188 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 1 | 2017-06-29 | reviewed by expert panel | curation | Synonymous substitution variant, with low bioinformatic likelihood to result in a splicing aberration (Splicing prior probability 0.02; http://priors.hci.utah.edu/PRIORS/). |
Eurofins Ntd Llc |
RCV000587715 | SCV000224989 | uncertain significance | not provided | 2014-09-05 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000855613 | SCV000698867 | likely benign | not specified | 2019-08-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001011536 | SCV001171869 | likely benign | Hereditary cancer-predisposing syndrome | 2019-03-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV001011536 | SCV001360029 | likely benign | Hereditary cancer-predisposing syndrome | 2019-05-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001413562 | SCV001615681 | likely benign | Hereditary breast ovarian cancer syndrome | 2023-06-09 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000495779 | SCV004818324 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 1 | 2023-04-03 | criteria provided, single submitter | clinical testing |